Initial Treatment Plan for Type 2 Diabetes
Metformin should be initiated as first-line therapy for most patients with type 2 diabetes at the time of diagnosis, along with comprehensive lifestyle modifications, unless contraindicated or not tolerated. 1
Pharmacologic Management
First-Line Therapy
- Start metformin at diagnosis if renal function is normal (eGFR ≥30 mL/min/1.73 m²) 2, 1
- Begin with 500mg once or twice daily
- Gradually increase to maximum effective dose of 1000mg twice daily
- Monitor for gastrointestinal side effects (bloating, abdominal discomfort, diarrhea)
- These side effects can be mitigated by gradual dose titration
Special Clinical Scenarios
For patients with marked hyperglycemia (blood glucose ≥250 mg/dL, A1C ≥8.5%) who are symptomatic with polyuria, polydipsia, nocturia, and/or weight loss:
- Initiate long-acting insulin while simultaneously starting metformin 2
- Titrate metformin to maximum tolerated dose
For patients with ketoacidosis:
- Start insulin therapy (intravenous or subcutaneous) to rapidly correct hyperglycemia and metabolic derangement
- Once acidosis resolves, initiate metformin while continuing insulin therapy 2
- Insulin can be tapered over 2-6 weeks by decreasing the dose 10-30% every few days once glucose targets are met 2
Lifestyle Modifications
Dietary Recommendations
- Focus on healthy eating patterns with nutrient-dense, high-quality foods 2, 1
- Decrease consumption of calorie-dense, nutrient-poor foods, especially sugar-sweetened beverages
- Emphasize consumption of non-starchy vegetables, whole fruits, legumes, whole grains, nuts, seeds, and low-fat dairy products
- Reduce intake of meat, sweets, refined grains, and processed or ultraprocessed foods 2
Physical Activity
- Encourage at least 150 minutes per week of moderate-intensity aerobic activity 1, 3
- Include muscle and bone strength training at least 3 days/week 2
- Decrease sedentary recreational screen time 2
- For patients with overweight/obesity, aim for 30-60 minutes of moderate-to-vigorous physical activity at least 5 days per week 1
Weight Management
- For patients with overweight/obesity, aim for a 7-10% decrease in excess weight 2, 1
- Provide developmentally and culturally appropriate comprehensive lifestyle programs integrated with diabetes management 2
Monitoring and Follow-up
Glycemic Monitoring
- Monitor HbA1c every 3 months until target is reached, then at least every 6 months 1
- Individualize HbA1c targets (generally <7.0%) based on patient factors 1
- For most children and adolescents with type 2 diabetes, a reasonable A1C goal is <7% 2
- Consider more stringent A1C goals (such as <6.5%) for selected individuals if they can be achieved without significant hypoglycemia 2
- Consider post-prandial glucose monitoring (target <180 mg/dL) if pre-prandial levels are in range but A1C remains elevated 1
Treatment Intensification
- If glycemic goals are not met with metformin monotherapy:
Important Considerations and Pitfalls
Medication Selection Pitfalls
- Failure to consider comorbidities when selecting medications:
Monitoring Pitfalls
- Inadequate monitoring of treatment response and side effects
- Failure to adjust therapy when targets are not met
- Not considering medication adherence issues before intensifying therapy
Education Pitfalls
- All patients with type 2 diabetes and their families should receive comprehensive diabetes self-management education and support that is culturally appropriate 2
- Failure to provide adequate education can lead to poor adherence and suboptimal outcomes
By following this treatment plan, patients with newly diagnosed type 2 diabetes can achieve optimal glycemic control while minimizing the risk of complications and improving long-term outcomes.